Determination of candesartan in human serum using high performance liquid chromatography and pharmacokinetics of candesartan cilexetil tablets in Chinese healthy volunteers

周玲洁,戴维,顾丽华,王以俭,黄仲义,梁建英

DOI: https://doi.org/10.3969/j.issn.1672-8467.2008.04.015

2008-01-01

Abstract:Objective To develop a sensitive and specific method for the determination of candesartan in human serum and to study the pharmacokinetics characteristics of candesartan cilexetil tablets in Chinese healthy volunteers using this method. Methods The samples were extracted from serum with diethyl ether. Chromatography was performed on an YMC® ODS column (250 mm x 4. 6 mm i. d. , 5 μm) with a mobile phase consisting of 10 mmol/L potassium dihydrogen phosphate (adjusted to pH 3. 0 with phosphoric acid) and acetonitrile (60 : 40, V/V) at a flow rate of 1. 0 mL/min. Quantification was performed by fluorescence detection at an excitation wavelength of 270 nm and an emission wavelength of 390 nm. A single oral dose of 8mg candesartan cilexetil tablet was given to 20 healthy volunteers. The candesartan concentrations in serum were determined by the above-mentioned method. The main pharmacokinetic parameters were detected and calculated. Results The linear range of candesartan concentration was 1. 01 to 202 μg/L in serum with a correlation coefficient (r) of 0.999 7. The relative standard deviations (RSDs) of intra-day and inter-day assays were 5. 22% - 9. 14% and 3. 58% - 10. 39%, respectively. Conclusions This method proved to be sensitive and reproducible for pharmacokinetic studies of candesartan cilexetil in healthy volunteers after a single oral administration (8 mg).